{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T11:27:45Z","timestamp":1782991665229,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014535","name":"Center for Individualized Medicine, Mayo Clinic","doi-asserted-by":"publisher","award":["J011972"],"award-info":[{"award-number":["J011972"]}],"id":[{"id":"10.13039\/100014535","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Artificial intelligence (AI) tools are more effective if accepted by clinicians. We developed an AI-based clinical decision support system (CDSS) to facilitate vancomycin dosing. This qualitative study assesses clinicians' perceptions regarding CDSS implementation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Thirteen semi-structured interviews were conducted with critical care pharmacists, at Mayo Clinic (Rochester, MN), from March through April 2020. Eight clinical cases were discussed with each pharmacist (<jats:italic>N<\/jats:italic>\u2009=\u2009104). Following initial responses, we revealed the CDSS recommendations to assess participants' reactions and feedback. Interviews were audio-recorded, transcribed, and summarized.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The participants reported considerable time and effort invested daily in individualizing vancomycin therapy for hospitalized patients. Most pharmacists agreed that such a CDSS could favorably affect (<jats:italic>N<\/jats:italic>\u2009=\u20098, 62%) or enhance (9, 69%) their ability to make vancomycin dosing decisions. In case-based evaluations, pharmacists' empiric doses differed from the CDSS recommendation in most cases (88\/104, 85%). Following revealing the CDSS recommendations, we noted 78% (69\/88) discrepant doses. In discrepant cases, pharmacists indicated they would not alter their recommendations. The reasons for declining the CDSS recommendation were general distrust of CDSS, lack of dynamic evaluation and in-depth analysis, inability to integrate all clinical data, and lack of a risk index.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>While pharmacists acknowledged enthusiasm about the advantages of AI-based models to improve drug dosing, they were reluctant to integrate the tool into clinical practice. Additional research is necessary to determine the optimal approach to implementing CDSS at the point of care acceptable to clinicians and effective at improving patient outcomes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12911-023-02254-9","type":"journal-article","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T06:01:33Z","timestamp":1691733693000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Discrepancy between perceptions and acceptance of clinical decision support Systems: implementation of artificial intelligence for vancomycin dosing"],"prefix":"10.1186","volume":"23","author":[{"given":"Xinyan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin F.","family":"Barreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Samie","family":"Tootooni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2184-3683","authenticated-orcid":false,"given":"Kianoush B.","family":"Kashani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,11]]},"reference":[{"key":"2254_CR1","doi-asserted-by":"crossref","unstructured":"Liu J, Kong X, Xia F, Bai X, Wang L, Qing Q, Lee I. Artificial Intelligence in the 21st Century, vol. 6. IEEE Access. 2018.","DOI":"10.1109\/ACCESS.2018.2819688"},{"issue":"2","key":"2254_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/13645706.2019.1575882","volume":"28","author":"Y Mintz","year":"2019","unstructured":"Mintz Y, Brodie R. Introduction to artificial intelligence in medicine. Minim Invasive Ther Allied Technol. 2019;28(2):73\u201381.","journal-title":"Minim Invasive Ther Allied Technol"},{"issue":"9","key":"2254_CR3","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1007\/s00134-019-05662-6","volume":"45","author":"M Komorowski","year":"2019","unstructured":"Komorowski M. Artificial intelligence in intensive care: are we there yet? Intensive Care Med. 2019;45(9):1298\u2013300.","journal-title":"Intensive Care Med"},{"issue":"2","key":"2254_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.amjmed.2017.10.035","volume":"131","author":"DD Miller","year":"2018","unstructured":"Miller DD, Brown EW. Artificial Intelligence in Medical Practice: The Question to the Answer? Am J Med. 2018;131(2):129\u201333.","journal-title":"Am J Med"},{"issue":"1","key":"2254_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.artmed.2008.07.017","volume":"46","author":"VL Patel","year":"2009","unstructured":"Patel VL, Shortliffe EH, Stefanelli M, Szolovits P, Berthold MR, Bellazzi R, Abu-Hanna A. The coming of age of artificial intelligence in medicine. Artif Intell Med. 2009;46(1):5\u201317.","journal-title":"Artif Intell Med"},{"issue":"1","key":"2254_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13054-020-2785-y","volume":"24","author":"G Gutierrez","year":"2020","unstructured":"Gutierrez G. Artificial Intelligence in the Intensive Care Unit. Crit Care. 2020;24(1):101.","journal-title":"Crit Care"},{"issue":"1","key":"2254_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","volume":"25","author":"EJ Topol","year":"2019","unstructured":"Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019;25(1):44\u201356.","journal-title":"Nat Med"},{"issue":"1","key":"2254_CR8","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13054-015-0801-4","volume":"19","author":"M Ghassemi","year":"2015","unstructured":"Ghassemi M, Celi LA, Stone DJ. State of the art review: the data revolution in critical care. Crit Care. 2015;19(1):118.","journal-title":"Crit Care"},{"issue":"11","key":"2254_CR9","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1007\/s00134-017-4808-y","volume":"43","author":"C Ince","year":"2017","unstructured":"Ince C. Intensive care medicine in 2050: the ICU in vivo. Intensive Care Med. 2017;43(11):1700\u20132.","journal-title":"Intensive Care Med"},{"key":"2254_CR10","doi-asserted-by":"crossref","unstructured":"Bleher H, Braun M. Diffused responsibility: attributions of responsibility in the use of AI-driven clinical decision support systems. AI Ethics. 2022;2(4):747\u201361.","DOI":"10.1007\/s43681-022-00135-x"},{"key":"2254_CR11","unstructured":"Patel S, Preuss CV, Bernice F. Vancomycin. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023."},{"issue":"Suppl 1","key":"2254_CR12","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1086\/491708","volume":"42","author":"RC Moellering Jr","year":"2006","unstructured":"Moellering RC Jr. Vancomycin: a 50-year reassessment. Clin Infect Dis. 2006;42(Suppl 1):S3-4.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2254_CR13","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1128\/AAC.01568-12","volume":"57","author":"SJ van Hal","year":"2013","unstructured":"van Hal SJ, Paterson DL, Lodise TP. Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter. Antimicrob Agents Chemother. 2013;57(2):734\u201344.","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"2254_CR14","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1097\/CCM.0000000000000514","volume":"42","author":"TP Hanrahan","year":"2014","unstructured":"Hanrahan TP, Harlow G, Hutchinson J, Dulhunty JM, Lipman J, Whitehouse T, Roberts JA. Vancomycin-associated nephrotoxicity in the critically ill: a retrospective multivariate regression analysis*. Crit Care Med. 2014;42(12):2527\u201336.","journal-title":"Crit Care Med"},{"key":"2254_CR15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jare.2019.10.005","volume":"21","author":"Y Cong","year":"2020","unstructured":"Cong Y, Yang S, Rao X. Vancomycin resistant Staphylococcus aureus infections: A review of case updating and clinical features. J Adv Res. 2020;21:169\u201376.","journal-title":"J Adv Res"},{"issue":"1","key":"2254_CR16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ijantimicag.2010.09.004","volume":"37","author":"A Jeurissen","year":"2011","unstructured":"Jeurissen A, Sluyts I, Rutsaert R. A higher dose of vancomycin in continuous infusion is needed in critically ill patients. Int J Antimicrob Agents. 2011;37(1):75\u20137.","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"2254_CR17","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/MCC.0b013e3283021b3a","volume":"14","author":"JA Roberts","year":"2008","unstructured":"Roberts JA, Lipman J, Blot S, Rello J. Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients? Curr Opin Crit Care. 2008;14(4):390\u20136.","journal-title":"Curr Opin Crit Care"},{"issue":"6","key":"2254_CR18","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1097\/FTD.0000000000000346","volume":"38","author":"K Hirai","year":"2016","unstructured":"Hirai K, Ishii H, Shimoshikiryo T, Shimomura T, Tsuji D, Inoue K, Kadoiri T, Itoh K. Augmented Renal Clearance in Patients With Febrile Neutropenia is Associated With Increased Risk for Subtherapeutic Concentrations of Vancomycin. Ther Drug Monit. 2016;38(6):706\u201310.","journal-title":"Ther Drug Monit"},{"issue":"12","key":"2254_CR19","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s00134-021-06549-1","volume":"47","author":"T De Corte","year":"2021","unstructured":"De Corte T, Elbers P, De Waele J. The future of antimicrobial dosing in the ICU: an opportunity for data science. Intensive Care Med. 2021;47(12):1481\u20133.","journal-title":"Intensive Care Med"},{"issue":"1","key":"2254_CR20","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1248\/bpb.b19-00729","volume":"43","author":"S Imai","year":"2020","unstructured":"Imai S, Takekuma Y, Miyai T, Sugawara M. A New Algorithm Optimized for Initial Dose Settings of Vancomycin Using Machine Learning. Biol Pharm Bull. 2020;43(1):188\u201393.","journal-title":"Biol Pharm Bull"},{"issue":"6","key":"2254_CR21","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1080\/17512433.2021.1911642","volume":"14","author":"X Huang","year":"2021","unstructured":"Huang X, Yu Z, Wei X, Shi J, Wang Y, Wang Z, Chen J, Bu S, Li L, Gao F, et al. Prediction of vancomycin dose on high-dimensional data using machine learning techniques. Expert Rev Clin Pharmacol. 2021;14(6):761\u201371.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"9","key":"2254_CR22","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1097\/ACM.0000000000000388","volume":"89","author":"BC O'Brien","year":"2014","unstructured":"O\u2019Brien BC, Harris IB, Beckman TJ, Reed DA, Cook DA. Standards for reporting qualitative research: a synthesis of recommendations. Acad Med. 2014;89(9):1245\u201351.","journal-title":"Acad Med"},{"issue":"11","key":"2254_CR23","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","volume":"77","author":"MJ Rybak","year":"2020","unstructured":"Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C, Mueller BA, Pai MP, Wong-Beringer A, Rotschafer JC, et al. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2020;77(11):835\u201364.","journal-title":"Am J Health Syst Pharm"},{"key":"2254_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/med\/9780199797783.001.0001","volume-title":"Mayo Clinic Antimicrobial Therapy: Quick Guide","author":"J EL Wilson","year":"2012","unstructured":"EL Wilson J. Mayo Clinic Antimicrobial Therapy: Quick Guide. 2nd ed. New York, NY: Oxford University Press Inc; 2012.","edition":"2"},{"issue":"3","key":"2254_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"2006","author":"VC Virginia Braun","year":"2006","unstructured":"Virginia Braun VC. Using thematic analysis in psychology. Qual Res Psychol [Internet]. 2006;2006(3):77\u2013101.","journal-title":"Qual Res Psychol [Internet]"},{"issue":"1","key":"2254_CR26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1586\/eri.09.123","volume":"8","author":"C Giuliano","year":"2010","unstructured":"Giuliano C, Haase KK, Hall R. Use of vancomycin pharmacokinetic-pharmacodynamic properties in the treatment of MRSA infections. Expert Rev Anti Infect Ther. 2010;8(1):95\u2013106.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2254_CR27","doi-asserted-by":"crossref","unstructured":"van der Veen A, Somers A, Vanhaesebrouck S, Ter Heine R, Br\u00fcggemann R, Allegaert K, De Cock P. Variation in vancomycin dosing and therapeutic drug monitoring practices in neonatal intensive care units. Int J Clin Pharm. 2022;44(2):564\u20139.","DOI":"10.1007\/s11096-021-01345-9"},{"issue":"5","key":"2254_CR28","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s10096-019-03769-8","volume":"39","author":"C Mabilat","year":"2020","unstructured":"Mabilat C, Gros MF, Nicolau D, Mouton JW, Textoris J, Roberts JA, Cotta MO, van Belkum A, Caniaux I. Diagnostic and medical needs for therapeutic drug monitoring of antibiotics. Eur J Clin Microbiol Infect Dis. 2020;39(5):791\u20137.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"23","key":"2254_CR29","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.2146\/ajhp140176","volume":"71","author":"DJ Gagnon","year":"2014","unstructured":"Gagnon DJ, Roberts R, Sylvia L. Implementation of the systems approach to improve a pharmacist-managed vancomycin dosing service. Am J Health Syst Pharm. 2014;71(23):2080\u20134.","journal-title":"Am J Health Syst Pharm"},{"key":"2254_CR30","doi-asserted-by":"publisher","first-page":"117863372095207","DOI":"10.1177\/1178633720952078","volume":"13","author":"AH Flannery","year":"2020","unstructured":"Flannery AH, Hammond DA, Oyler DR, Li C, Wong A, Smith AP, Yeo QM, Chaney W, Pfaff CE, Plewa-Rusiecki AM, et al. Vancomycin Dosing Practices among Critical Care Pharmacists: A Survey of Society of Critical Care Medicine Pharmacists. Infect Dis (Auckl). 2020;13:1178633720952078.","journal-title":"Infect Dis (Auckl)"},{"issue":"3","key":"2254_CR31","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1086\/600877","volume":"49","author":"MJ Rybak","year":"2009","unstructured":"Rybak MJ, Lomaestro BM, Rotschafer JC, Moellering RC, Craig WA, Billeter M, Dalovisio JR, Levine DP. Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis. 2009;49(3):325\u20137.","journal-title":"Clin Infect Dis"},{"issue":"18","key":"2254_CR32","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1001\/jama.2019.15064","volume":"322","author":"WN Price 2nd","year":"2019","unstructured":"Price WN 2nd, Gerke S, Cohen IG. Potential Liability for Physicians Using Artificial Intelligence. JAMA. 2019;322(18):1765\u20136.","journal-title":"JAMA"},{"issue":"9","key":"2254_CR33","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1007\/s00134-017-5034-3","volume":"44","author":"S Bailly","year":"2018","unstructured":"Bailly S, Meyfroidt G, Timsit JF. What\u2019s new in ICU in 2050: big data and machine learning. Intensive Care Med. 2018;44(9):1524\u20137.","journal-title":"Intensive Care Med"},{"issue":"22","key":"2254_CR34","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1001\/jama.2016.17217","volume":"316","author":"AL Beam","year":"2016","unstructured":"Beam AL, Kohane IS. Translating Artificial Intelligence Into Clinical Care. JAMA. 2016;316(22):2368\u20139.","journal-title":"JAMA"},{"issue":"1","key":"2254_CR35","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41591-018-0310-5","volume":"25","author":"O Gottesman","year":"2019","unstructured":"Gottesman O, Johansson F, Komorowski M, Faisal A, Sontag D, Doshi-Velez F, Celi LA. Guidelines for reinforcement learning in healthcare. Nat Med. 2019;25(1):16\u20138.","journal-title":"Nat Med"},{"key":"2254_CR36","doi-asserted-by":"crossref","unstructured":"Zhang Y, Liao QV, Bellamy RKE. Effect of confidence and explanation on accuracy and trust calibration in AI-assisted decision making. In: Proceedings of the 2020 Conference on Fairness, Accountability, and Transparency. Barcelona: Association for Computing Machinery; 2020. p. 295\u2013305.","DOI":"10.1145\/3351095.3372852"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-023-02254-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-023-02254-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-023-02254-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T21:27:59Z","timestamp":1700256479000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-023-02254-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,11]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2254"],"URL":"https:\/\/doi.org\/10.1186\/s12911-023-02254-9","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,11]]},"assertion":[{"value":"17 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was deemed exempt by the institutional review board of Mayo Clinic, Rochester, MN (#19\u2013010472). All participants provided verbal consent to contribute to the interview. The Mayo Clinic, Institutional Review Board, agreed to obtain verbal instead of oral contrast as the study carried minimal risk based on the assessment of the IRB. The verbal consent script (provided as supplementary material) was read to the participants, and they only entered the interviews when they agreed with the content of the verbal consent. Therefore, pharmacists who rejected the verbal consent (all pharmacists who were approached agreed to contribute) did not participate in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the authors had any conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"157"}}